Skip to content
Opinion
Lisa Jarvis

Progress on HPV Vaccines Is Too Important to Lose

Thanks to the pandemic and various legal challenges, HPV vaccination rates have flatlined. 

Not controversial.

Not controversial.

Photographer: Bloomberg

HPV vaccinations among teens in the US dropped precipitously during the early pandemic, a disappointing reversal for shots that can prevent more than 33,000 cases of cancer each year. Worse, efforts to get vaccinations back on track could be stymied by legal challenges.

We can’t let a decade worth of slow and steady progress in HPV vaccinations be lost.